መነሻ › ሲስቲክ ፋይብሮሲስ › ማሳቹሴትስ
በማሳቹሴትስ ለሲስቲክ ፋይብሮሲስ የሚደረጉ ክሊኒካዊ ጥናቶች
ለሲስቲክ ፋይብሮሲስ የሚደረጉ 17 ጥናቶች በማሳቹሴትስ ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።
በማሳቹሴትስ ውስጥ ያሉ ከተሞች
Official study text (English)
Phase 2 Study to Assess the Safety and Efficacy of ANG003
- Massachusetts General Hospital, Boston
- Boston Children's Hospita, Boston
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 12 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT07450547Streamlined Treatment of Pulmonary Exacerbations in Pediatrics
- Boston Children's Hospital & Harvard University, Boston
ተሳታዮችን በመፈለግ ላይ
እድሜ ከ3 እስከ 18 · ሁሉም ጾታዎች · የተሻሻለው በ3 ኦገስ 2026 · NCT06654752Study to Evaluate Biological & Clinical Effects of Significantly Corrected CFTR Function in Infants & Young Children
- Boston Children's Hospital, Boston
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እስከ እድሜ 10 · ሁሉም ጾታዎች · የተሻሻለው በ8 ጁላይ 2026 · NCT04509050Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study
- Boston Children's Hospital, Brigham & Women's Hospital, Boston
- University of Massachusetts Memorial Health Care, Worcester
ተሳታዮችን በመፈለግ ላይደረጃ 4
እድሜ 6 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ8 ጁላይ 2026 · NCT055482834D-710 in Adult Patients With Cystic Fibrosis
- Massachusetts General Hospital, Boston
- Boston Children's Hospital, Boston
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ6 ጁላይ 2026 · NCT05248230TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age
- Massachusetts General Hospital, Boston
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
18 Months – 11 Years · ሁሉም ጾታዎች · የተሻሻለው በ6 ጁላይ 2026 · NCT07048574Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPL84 in Patients With Cystic Fibrosis
- Boston Children'S Hospital, Boston
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ14 ሜይ 2026 · NCT06429176Safety, Tolerability and Efficacy Study of ARCT-032 in People With Cystic Fibrosis
- Boston Children's Hospital, Boston
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ8 ሜይ 2026 · NCT06747858CF Wellness Program
- Boston Children's Hospital, Boston
ተሳታዮችን በመፈለግ ላይ
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ13 ፌብሩ 2026 · NCT07071324Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
- Massachusetts, Boston
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ 12 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ10 ፌብሩ 2026 · NCT06837181OnTrackCF: Engagement, Feasibility, and Acceptability Study
- Boston Children's Hospital, Boston
ተሳታዮችን በመፈለግ ላይ
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ5 ዲሴም 2025 · NCT07031323Health Outcomes of Parents With Cystic Fibrosis-Aim 2
- Massachusetts General Hospital, Boston
- Boston Children's Hospital/Brigham and Women's Hospital, Boston
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ10 ኖቬም 2025 · NCT06296394Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL)
- Massachusetts General Hospital, Boston
- Boston Children's Hospital, Boston
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ 6 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ3 ኖቬም 2025 · NCT06683092Skeletal Health and Bone Marrow Composition in Adolescents With Cystic Fibrosis
- Boston Children's Hospital, Boston
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
እድሜ ከ13 እስከ 20 · ሁሉም ጾታዎች · የተሻሻለው በ30 ኦክቶ 2025 · NCT06216704A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
- Massachusetts General Hospital, Boston
- Boston Children's Hospital, Boston
- University of Massachusetts Memorial Health Care, Worcester
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ 12 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2025 · NCT06504589The Effects of a Low Glycemic Load Diet on Dysglycemia and Body Composition in Adults With Cystic Fibrosis-Related Diabetes
- Boston Children's Hospital, Boston
ተሳታዮችን በመፈለግ ላይ
እድሜ ከ18 እስከ 70 · ሁሉም ጾታዎች · የተሻሻለው በ22 ኦገስ 2025 · NCT05723445A Phase 1/2 Trial of SP-101 for the Treatment of Cystic Fibrosis (CF)
- Boston Children's Hospital, Brigham & Women's Hospital, Boston
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ ከ18 እስከ 65 · ሁሉም ጾታዎች · የተሻሻለው በ25 ኖቬም 2024 · NCT06526923ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።